DBVT DBV Technologies S.A.: institutional ownership and insider trading
72 funds reported holding $343M of DBV Technologies S.A. in their latest 13F filings; in Q2 2026 funds net bought $5.64M, with 17 new positions and 11 funds selling out; over the last 12 months insiders bought $0 and sold $15.5M on the open market.
Famous investors holding DBVT
- Stanley Druckenmiller (Duquesne Family Office): $6.29M, 0.1% of the portfolio
- Izzy Englander (Millennium Management): $4.39M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $374K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $191K, 0.0% of the portfolio
Largest institutional holders of DBVT
- MPM BioImpact LLC — $60.1M
- Siren, L.L.C. — $30.5M
- Vivo Capital, LLC — $30.3M
- PERCEPTIVE ADVISORS LLC — $27.1M
- BAKER BROS. ADVISORS LP — $24.0M
- Artisan Partners Limited Partnership — $22.5M
- UBS Group AG (UBS) — $21.5M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $15.7M
- Logos Global Management LP — $15.0M
- Patient Square Capital LP — $14.9M
Recent DBVT insider trades
- Jul 29, 2026: Mohideen Pharis sold 464 shares ($1.25K)
- Jan 29, 2026: Mohideen Pharis sold 534 shares ($2.60K)
- Dec 18, 2025: Caisse Des Depots Et Consignations sold 3,369,093 shares ($15.5M)
- Nov 21, 2025: Mohideen Pharis sold 8,120 shares ($23.2K)
5%+ owners
- Adage Capital Management, L.P.: 7.3% (Schedule 13G/A, filed May 13, 2026)
- Raymond Debbane: 6.5% (Schedule 13G/A, filed May 5, 2026)
- MPM BioImpact LLC: 6.2% (Schedule 13G/A, filed Aug 14, 2026)
- RA Capital Management, L.P.: 5.8% (Schedule 13G, filed Aug 6, 2026)